Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Phospholipase A inhibition of opiate receptor binding can be reversed by albumin

Abstract

OPIATE receptors in animal and human brain have been shown to be tightly associated with cell membranes1–3. Our laboratory has reported the solubilisation of an etorphine–receptor complex4, but to date it has not been possible to obtain an active receptor in soluble form. Nevertheless, it has been possible to study many biochemical characteristics of the membrane-bound receptor. Its sensitivity to sulphhydryl reagents and a number of other protein reagents5,6 as well as to proteolytic enzymes1,7 suggests the participation of protein(s) in opiate binding. The evidence is less clear with respect to a function for phospholipids. Opiate binding activity of cell membrane preparations from rat brain has been shown to be exquisitely sensitive to phospholipase A of Vipera russelli venom (in the ng ml−1 range)8, but very insensitive to phospholipase A present in the venom of Crotalus adamenteus1 or that derived from pig pancreas (Lin & Simon, unpublished). Phospholipase C is inhibitory only in very high concentrations1,8. The great sensitivity of opiate receptors to the Russell's viper enzyme and to ionic and non-ionic detergents4,7 points to a possible role for phospholipids in the binding process. We report here that inhibition of opiate binding by phospholipase A can be reversed almost completely by incubation of the enzyme-treated membranes with bovine serum albumin (BSA).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Simon, E. J., Hiller, J. M. & Edelman, I. Proc. natn. Acad. Sci. U.S.A. 70, 1947–1949 (1973).

    Article  ADS  CAS  Google Scholar 

  2. Pert, C. B. & Snyder, S. H. Science 179, 1011–1014 (1973).

    Article  ADS  CAS  Google Scholar 

  3. Terenius, L. Acta pharmac. toxicol. 32, 317–320 (1973).

    Article  CAS  Google Scholar 

  4. Simon, E. J., Hiller, J. M. & Edelman, I. Science 190, 389–390 (1975).

    Article  ADS  CAS  Google Scholar 

  5. Simon, E. J. & Groth, J. Proc. natn. Acad. Sci. U.S.A. 72, 2404–2407 (1975).

    Article  ADS  CAS  Google Scholar 

  6. Pasternak, G. W., Wilson, H. A. & Snyder, S. H. Molec. Pharmac. 11, 340–351 (1975).

    CAS  Google Scholar 

  7. Pasternak, G. W. & Snyder, S. H. Molec. Pharmac. 10, 183–193 (1974).

    CAS  Google Scholar 

  8. Pasternak, G. W. & Snyder, S. H. Molec. Pharmac. 11, 478–484 (1975).

    CAS  Google Scholar 

  9. Simon, E. J., Hiller, J. M., Groth, J. & Edelman, I. J. Pharmac. exp. Ther. 192, 531–537 (1975).

    CAS  Google Scholar 

  10. Azhar, S., Hajra, A. K. & Menon, K. M. J. J. biol. Chem. 251, 7405–7412 (1976).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

LIN, HK., SIMON, E. Phospholipase A inhibition of opiate receptor binding can be reversed by albumin. Nature 271, 383–384 (1978). https://doi.org/10.1038/271383a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/271383a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing